This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,119.35 contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a prescription medication. The contract has an ultimate completion date of May 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,236.30 firm fixed price delivery order is for the supply of REYVOW 100 MG TABLET UD 8S, a prescription medication. The contract has a completion date of June 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,226.31 firm fixed-price contract is for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of October 25, 2022. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REYVOW 100 MG TABLET UD 8S. The award, valued at $1,473.87, is a firm fixed-price delivery order contract with an ultimate completion date of August 19, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,226.31 firm fixed-price delivery order covers the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,678.47, is a delivery order for the medical product "REYVOW 50 MG TABLET UD 8S". It is a firm fixed-price contract with an ultimate completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,466.28 firm-fixed-price delivery order is for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,452.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with an ultimate completion date of December 3, 2024. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. No set-aside designation was used for this award. AmerisourceBergen Drug...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The award, valued at $1,613.49, is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a performance period ending on March 22, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,520.77 firm-fixed-price contract is for the delivery of 4,566,211,365 units of the prescription medication Reyvow 100 mg tablets. The contract has an ultimate completion date of October 28, 2024 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...